July 2, 2009 03:41 PM EDT

Recombinant interferon-alpha may delay onset of type 1 diabetes in young patients

Young patients with type 1 diabetes assigned to low doses of human recombinant interferon-alpha treatment maintained more beta-cell function one year following study enrollment when compared with placebo-matched controls — the effect did not occur in patients who received high-dose,...

FULL STORY

Calendar
August 5, 2009

American Association of Diabetes Educators 2009 Annual Meeting & Exhibition; Atlanta

Atlanta, ga United States of America

more information »

Quote of the day

"One point has become abundantly clear, and this is that cancer must now be numbered among the complications of diabetes..."

Click here to read full entry. »

Featured Story

Experts discussed need for long-term effects of oral agents to treat gestational diabetes

A recent study in the New England Journal of Medicine showed that treatment with metformin when compared with treatment with insulin was not associated with increased perinatal complications in women with gestational diabetes. Women in the study also preferred metformin. “The results are encouraging,” said James Lenhard, MD, medical director of Christiana Care Health System’s Diabetes & Metabolic Disease Center, Wilmington, Del...

FULL STORY

Endocrine Today by the numbers
Meta-analysis: Intensive Glycemic Control Reduced Coronary Events Without Increased Risk for Death
By the numbers
[+] more information »